A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men

被引：16
作者：
Fowke J.H. [1 ,4 ]
Han X. [2 ]
Alderete J.F. [3 ]
Moses K.A. [4 ]
Signorello L.B. [5 ]
Blot W.J. [1 ,2 ]
机构：
[1] Departments of Medicine, Institute of Medicine and Public Health, Vanderbilt University Medical Center, 2525 West End Ave, 12th floor, Nashville, 37232, TN
[2] International Epidemiology Institute, Rockville, MD
[3] School of Molecular Biosciences, Washington State University, Pullman, WA
[4] Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville
[5] Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD
来源：
BMC Research Notes | / 9卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Prostate cancer; Race; Trichomonas vaginalis;
D O I：
10.1186/s13104-016-2033-3
中图分类号：
学科分类号：
摘要：
Background: African Americans (AA) have a higher prevalence of Trichomonas vaginalis (Tv) infection and a higher prostate (PC) risk. Past studies suggest an association between Tv seropositivity and PC, and therefore we prospectively investigated this association among AA men. Results: Incident PC cases were individually matched to controls in a nested case-control study within the Southern Community Cohort Study (SCCS). Primary analysis included 296 PC cases and 497 race-matched controls. Levels of Tv antibody response were measured by ELISA in serum collected at baseline. Tv antibody response did not significantly differ between cases and controls overall or within AA participants (253 AA cases). There were no significant associations or trends between levels of Tv response and PC risk or the diagnosis of aggressive PC. Conclusion: We found no evidence of a prospective association between baseline Tv infection and PC risk in AA men. Tv infection in men may have substantial health implications in HIV transmission and reproductive outcomes, but may not impact future PC risk in AA men at high-risk for PC. Further efforts need to define past vs. present Tv infection and to separate pathophysiology from PC detection. © 2016 Fowke et al.
引用
收藏
相关论文
共 10 条
  • [1] Chen Y., Huang Y., Platz E., Alderete J., Zheng L., Rider J., Kraft P., Giovannucci E., Sutcliffe S., Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer, Cancer Causes Control, 24, 1, pp. 175-180, (2013)
  • [2] Stark J.R., Judson G., Alderete J.F., Mundodi V., Kucknoor A.S., Giovannucci E.L., Platz E.A., Sutcliffe S., Fall K., Kurth T., Et al., Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' health study, J Natl Cancer Inst, 101, 20, pp. 1406-1411, (2009)
  • [3] Sutcliffe S., Giovannucci E., Alderete J.F., Chang T.-H., Gaydos C.A., Zenilman J.M., De Marzo A.M., Willett W.C., Platz E.A., Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, 15, 5, pp. 939-945, (2006)
  • [4] Sutcliffe S., Alderete J.F., Till C., Goodman P.J., Hsing A.W., Zenilman J.M., De Marzo A.M., Platz E.A., Trichomonosis and subsequent risk of prostate cancer in the prostate cancer prevention trial, Int J Cancer, 124, 9, pp. 2082-2087, (2009)
  • [5] Shui I.M., Kolb S., Hanson C., Sutcliffe S., Rider J.R., Stanford J.L., Trichomonas vaginalis infection and risk of advanced prostate cancer, Prostate, (2016)
  • [6] Miller W.C., Swygard H., Hobbs M.M., Ford C.A., Handcock M.S., Morris M., Schmitz J.L., Cohen M.S., Harris K.M., Udry J.R., The prevalence of Trichomoniasis in young adults in the United States, Sex Transm Dis, 32, 10, pp. 593-598, (2005)
  • [7] Signorello L.B., Hargreaves M.K., Steinwandel M.D., Zheng W., Cai Q., Schlundt D.G., Buchowski M.S., Arnold C.W., McLaughlin J.K., Blot W.J., Southern community cohort study: Establishing a cohort to investigate health disparities, J Natl Med Assoc, 97, 7, pp. 972-979, (2005)
  • [8] Neace C.J., Alderete J.F., Epitopes of the highly immunogenic Trichomonas vaginalis alpha-actinin are serodiagnostic targets for both women and men, J Clin Microbiol, 51, 8, pp. 2483-2490, (2013)
  • [9] Breyer B.N., Huang W.-Y., Rabkin C.S., Alderete J.F., Pakpahan R., Beason T.S., Kenfield S.A., Mabie J., Ragard L., Wolin K.Y., Et al., Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: Results from the prostate, lung, colorectal and ovarian cancer screening trial, BJU Int, 117, 1, pp. 145-154, (2016)
  • [10] Sutcliffe S., Alderete J.F., Neace C., Joyce P.A., Gaydos C.A., Huth J.I.A., Mucci L.A., Signorello L.B., Persistence of Trichomonas vaginalis serostatus in men over time, Cancer Cause Control, 26, 10, pp. 1461-1466, (2015)
1